{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:57:43Z","timestamp":1791867463701,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K11100"],"award-info":[{"award-number":["21K11100"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K11100"],"award-info":[{"award-number":["21K11100"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81698-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:04:58Z","timestamp":1733223898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report database"],"prefix":"10.1038","volume":"14","author":[{"given":"Kiyoka","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koumi","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Hirofuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanaka","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"81698_CR1","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2147\/DMSO.S212003","volume":"12","author":"S Bryce","year":"2019","unstructured":"Bryce, S. & Gordon, M. Sodium-glucose cotranspoter-2(SGLT2) inhibitors: a clinician\u2019s guide. Diabetes Metab. Syndr. Obes. 12, 2125\u20132136 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"81698_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/clpt.2008.251","volume":"85","author":"B Komoroski","year":"2009","unstructured":"Komoroski, B. et al. Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects. Clin. Pharmacol. Ther. 85, 520\u2013526 (2009).","journal-title":"Clin. Pharmacol. Ther."},{"key":"81698_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13300-021-01004-2","volume":"12","author":"TM Caparrotta","year":"2021","unstructured":"Caparrotta, T. M. et al. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) exposure and outcomes in type 2 diabetes: A systematic review of population-based observational studies. Diabetes Ther. 12, 991\u20131028 (2021).","journal-title":"Diabetes Ther."},{"key":"81698_CR4","doi-asserted-by":"publisher","first-page":"e2924","DOI":"10.1002\/dmrr.2924","volume":"33","author":"JE Blau","year":"2017","unstructured":"Blau, J. E., Tella, S. H., Taylor, S. I. & Rother, K. I. Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data. Diabetes Metab. Res. Rev. 33, e2924 (2017).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"81698_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00125-017-4301-8","volume":"60","author":"GP Fadini","year":"2017","unstructured":"Fadini, G. P., Bonora, B. M. & Avogaro, A. SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA adverse event reporting system. Diabetologia 60, 1385\u20131389 (2017).","journal-title":"Diabetologia"},{"key":"81698_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/dbi20-0040","volume":"70","author":"KR Tuttle","year":"2021","unstructured":"Tuttle, K. R. et al. SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: Report of a scientific workshop sponsored by the national kidney foundation. Diabetes 70, 1\u201316 (2021).","journal-title":"Diabetes"},{"key":"81698_CR7","doi-asserted-by":"publisher","first-page":"k4365","DOI":"10.1136\/bmj.k4365","volume":"363","author":"P Ueda","year":"2018","unstructured":"Ueda, P. et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: Nationwide register based cohort study. BMJ 363, k4365 (2018).","journal-title":"BMJ"},{"key":"81698_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.7150\/ijms.22224","volume":"15","author":"T Sakaeda","year":"2018","unstructured":"Sakaeda, T. et al. Susceptibility to serious skin and subcutaneous tissue disorder and skin tissue distribution of sodium-dependent glucose co-transporter type-2 (SGLT2) inhibitors. Int. J. Med. Sci. 15, 937\u2013943 (2018).","journal-title":"Int. J. Med. Sci."},{"key":"81698_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1248\/bpb.b17-00561","volume":"40","author":"S Nakao","year":"2018","unstructured":"Nakao, S. et al. Evaluation of drug-induced photosensitivity using the Japanese adverse drug Event Report (JADER) database. Biol. Pharm. Bull. 40, 2158\u20132165 (2018).","journal-title":"Biol. Pharm. Bull."},{"key":"81698_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40801-016-0081-6","volume":"3","author":"O Marrero","year":"2016","unstructured":"Marrero, O., Hung, E. Y. & Hauben, M. Seasonal and geographic variation in adverse event reporting. Drugs Real. World Outcomes. 3, 297\u2013306 (2016).","journal-title":"Drugs Real. World Outcomes"},{"key":"81698_CR11","unstructured":"Japan Meteorological Agency. Tokyo (Japan) monthly average of daily mean temperature (\u00b0C), https:\/\/www.data.jma.go.jp\/obd\/stats\/etrn\/view\/monthly_s3.php?prec_no=44_no=47662, cited 29 June, 2024."},{"key":"81698_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/ggi.14010","volume":"20","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. et al. Seasonal variation in hydration status among community-dwelling elderly in Japan. Geriatr. Gerontol. Int. 20, 904\u2013910 (2020).","journal-title":"Geriatr. Gerontol. Int."},{"key":"81698_CR13","first-page":"19","volume":"8","author":"M Tsutsumi","year":"2003","unstructured":"Tsutsumi, M., Sato, M. & Kobayashi, T. A study on seasonal changes of the amount of body water of elderly people in a care house in summer and winter using the electrical impedance method. Bull. School Nurs. Yamaguchi Prefectural Univ. 8, 19\u201323 (2003).","journal-title":"Bull. School Nurs. Yamaguchi Prefectural Univ."},{"key":"81698_CR14","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.3390\/ijerph19095627","volume":"19","author":"O Joanna","year":"2022","unstructured":"Joanna, O., Magdalena, M. & Pawe\u0142, T. Hydration status in men working in different thermal environments: A pilot study. Int. J. Environ. Res. Public. Health. 19, 5627 (2022).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"81698_CR15","doi-asserted-by":"publisher","first-page":"1230574","DOI":"10.3389\/fneur.2023.1230574","volume":"14","author":"A Fukunaga","year":"2023","unstructured":"Fukunaga, A., Koyama, H., Fuse, T. & Haraguchi, A. The onset of cerebral infarction may be affected by differences in atmospheric pressure distribution patterns. Front. Neurol. 14, 1230574 (2023).","journal-title":"Front. Neurol."},{"key":"81698_CR16","first-page":"299","volume":"41","author":"K Bhatia","year":"2015","unstructured":"Bhatia, K., Mohanty, S., Tripathi, B. K., Gupta, T. B. & Mittal, M. K. Predictors of early neurological deterioration in patients with acute ischemic stroke with special reference to blood urea nitrogen (BUN)\/creatinine ratio and urine specific gravity. Indian J. Med. Res. 41, 299\u2013307 (2015).","journal-title":"Indian J. Med. Res."},{"key":"81698_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch, E. C. et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44, 870\u2013947 (2013).","journal-title":"Stroke"},{"key":"81698_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/qjmed\/hch050","volume":"97","author":"J Kelly","year":"2004","unstructured":"Kelly, J. et al. Dehydration and venous thromboembolism after acute stroke. QJM 97, 293\u2013296 (2004).","journal-title":"QJM"},{"key":"81698_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00484-014-0917-2","volume":"59","author":"YH Lim","year":"2015","unstructured":"Lim, Y. H., Park, M. S., Kim, Y., Kim, H. & Hong, Y. C. Effects of cold and hot temperature on dehydration: A mechanism of cardiovascular burden. Int. J. Biometeorol. 59, 1035\u20131043 (2015).","journal-title":"Int. J. Biometeorol."},{"key":"81698_CR20","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41440-021-00732-z","volume":"44","author":"K Narita","year":"2021","unstructured":"Narita, K., Hoshide, S. & Kario, K. Seasonal variation in blood pressure: Current evidence and recommendations for hypertension management. Hypertens. Res. 44, 1363\u20131372 (2021).","journal-title":"Hypertens. Res."},{"key":"81698_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s13300-024-01613-7","volume":"15","author":"T Imai","year":"2024","unstructured":"Imai, T. et al. Risk of urogenital bacterial infection with sodium-glucose cotransporter-2 inhibitors: A retrospective cohort study using a claims database. Diabetes Ther. 15, 1821\u20131830 (2024).","journal-title":"Diabetes Ther."},{"key":"81698_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7326\/M18-3136","volume":"171","author":"CV Dave","year":"2019","unstructured":"Dave, C. V. et al. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: A population-based cohort study. Ann. Intern. Med. 171, 248\u2013256 (2019).","journal-title":"Ann. Intern. Med."},{"key":"81698_CR23","unstructured":"Pharmaceuticals and Medical Devices Agency, Canaglu\u00ae (canagliflozin) (Approval. (2014). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/400315_3969022F1029_1_22, cited 14 September, 2024."},{"key":"81698_CR24","unstructured":"Pharmaceuticals and Medical Devices Agency, Jardiance\u00ae (empagliflozin) (Approval: 2015), (2024). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/650168_3969023F1023_1_17, cited 14."},{"key":"81698_CR25","unstructured":"Pharmaceuticals and Medical Devices Agency, Suglat\u00ae (ipragliflozin) (Approval: 2014), (2024). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/800126_3969018F1022_1_14, cited 14."},{"key":"81698_CR26","unstructured":"Pharmaceuticals and Medical Devices Agency, Canalia\u00ae (canagliflozin, teneligliptin) combination tablets (Approval: 2017), (2024). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/400315_3969106F1028_1_14, cited 14."},{"key":"81698_CR27","unstructured":"Pharmaceuticals and Medical Devices Agency, Tradiance\u00ae (empagliflozin, linagliptin) combination tablets (Approval: 2018), (2024). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/650168_3969108F1027_1_04, cited 14."},{"key":"81698_CR28","unstructured":"Pharmaceuticals and Medical Devices Agency, Sujanu\u00ae (ipragliflozin, sitagliptin) combination tablets (Approval: 2018), (2024). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/170050_3969107F1022_1_09, cited 14."},{"key":"81698_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans, S. J., Waller, P. C. & Davis, S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 10, 483\u2013486 (2001).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"81698_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1248\/bpbreports.7.3_76","volume":"7","author":"N Ichihara","year":"2024","unstructured":"Ichihara, N. et al. Analysis of metformin-associated lactic acidosis using Japanese adverse drug event report database. BPB Rep. 7, 76\u201380 (2024).","journal-title":"BPB Rep."},{"key":"81698_CR31","doi-asserted-by":"publisher","first-page":"122789","DOI":"10.1016\/j.jns.2023.122789","volume":"455","author":"S Sakurai","year":"2023","unstructured":"Sakurai, S. et al. Progressive multifocal leukoencephalopathy analyzed using the Japanese adverse drug Event Report database. J. Neurol. Sci. 455, 122789 (2023).","journal-title":"J. Neurol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81698-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81698-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81698-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:06:39Z","timestamp":1733227599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81698-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81698"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81698-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not sought for this study because the study was a database-related observational study which did not directly involve any research subjects. All results were obtained from data openly available online from the PMDA website (). All data from the JADER database were fully anonymized by the relevant regulatory authority before we accessed them.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Our research does not fall within the purview of any of the following laws and guidelines: \u201cClinical Trials Act (Act No. 16 of April 14, 2017),\u201d \u201cAct on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Law number: Act No. 145 of 1960, Last Version: Amendment of Act No. 50 of 2015),\u201d \u201cGuideline for good clinical practice E6 (R1), ,\u201d \u201cEthical guidelines for human genome and gene analysis research, ,\u201d and \u201cEthical Guidelines for Medical and Health Research Involving Human Subjects, .\u201d Therefore, it is not subject to ethical examination. The study was an observational study without any research subjects. No consent to participate was required due to the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30072"}}